These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 24990506

  • 1. Synthesis and structure-activity relationship study of triazine-based inhibitors of the DNA binding of NF-κB.
    Fujii S, Kobayashi T, Nakatsu A, Miyazawa H, Kagechika H.
    Chem Pharm Bull (Tokyo); 2014; 62(7):700-8. PubMed ID: 24990506
    [Abstract] [Full Text] [Related]

  • 2. A new small molecule that directly inhibits the DNA binding of NF-kappaB.
    Kobayashi T, Yoshimori A, Kino K, Komori R, Miyazawa H, Tanuma SI.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5293-7. PubMed ID: 19539480
    [Abstract] [Full Text] [Related]

  • 3. Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA binding.
    Sharma RK, Otsuka M, Pande V, Inoue J, João Ramos M.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6123-7. PubMed ID: 15546742
    [Abstract] [Full Text] [Related]

  • 4. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships.
    Sharma RK, Chopra S, Sharma SD, Pande V, Ramos MJ, Meguro K, Inoue J, Otsuka M.
    J Med Chem; 2006 Jun 15; 49(12):3595-601. PubMed ID: 16759101
    [Abstract] [Full Text] [Related]

  • 5. Fluorescent thermal shift-based method for detection of NF-κB binding to double-stranded DNA.
    Leitner PD, Vietor I, Huber LA, Valovka T.
    Sci Rep; 2021 Jan 27; 11(1):2331. PubMed ID: 33504856
    [Abstract] [Full Text] [Related]

  • 6. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
    Johansen C, Flindt E, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L.
    J Invest Dermatol; 2005 Jun 27; 124(6):1284-92. PubMed ID: 15955105
    [Abstract] [Full Text] [Related]

  • 7. Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity.
    Loop T, Humar M, Pischke S, Hoetzel A, Schmidt R, Pahl HL, Geiger KK, Pannen BH.
    Anesthesiology; 2003 Aug 27; 99(2):360-7. PubMed ID: 12883408
    [Abstract] [Full Text] [Related]

  • 8. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.
    Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC.
    Mol Pharmacol; 2005 Aug 27; 68(2):286-97. PubMed ID: 15872117
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
    Choi M, Jo H, Park HJ, Sateesh Kumar A, Lee J, Yun J, Kim Y, Han SB, Jung JK, Cho J, Lee K, Kwak JH, Lee H.
    Bioorg Med Chem Lett; 2015 Jun 15; 25(12):2545-9. PubMed ID: 25953156
    [Abstract] [Full Text] [Related]

  • 10. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner.
    Leung CH, Grill SP, Lam W, Gao W, Sun HD, Cheng YC.
    Mol Pharmacol; 2006 Dec 15; 70(6):1946-55. PubMed ID: 16940413
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes.
    Brabec V, Kasparkova J, Kostrhunova H, Farrell NP.
    Sci Rep; 2016 Aug 30; 6():28474. PubMed ID: 27574114
    [Abstract] [Full Text] [Related]

  • 12. Electrophoretic mobility shift assay analysis of NF-κB DNA binding.
    Ramaswami S, Hayden MS.
    Methods Mol Biol; 2015 Aug 30; 1280():3-13. PubMed ID: 25736740
    [Abstract] [Full Text] [Related]

  • 13. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
    Trinh DV, Zhu N, Farhang G, Kim BJ, Huxford T.
    J Mol Biol; 2008 May 23; 379(1):122-35. PubMed ID: 18436238
    [Abstract] [Full Text] [Related]

  • 14. Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system.
    Okvist A, Johansson S, Kuzmin A, Bazov I, Merino-Martinez R, Ponomarev I, Mayfield RD, Harris RA, Sheedy D, Garrick T, Harper C, Hurd YL, Terenius L, Ekström TJ, Bakalkin G, Yakovleva T.
    PLoS One; 2007 Sep 26; 2(9):e930. PubMed ID: 17895971
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents.
    Choi M, Jo H, Kim D, Yun J, Kang JS, Kim Y, Jung JK, Hong JT, Cho J, Kwak JH, Lee H.
    Arch Pharm Res; 2016 May 26; 39(5):618-30. PubMed ID: 27021311
    [Abstract] [Full Text] [Related]

  • 16. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B, Tonddast-Navaei S, Skolnick J.
    Eur J Med Chem; 2015 Oct 20; 103():600-14. PubMed ID: 26414808
    [Abstract] [Full Text] [Related]

  • 17. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.
    Borgatti M, Chilin A, Piccagli L, Lampronti I, Bianchi N, Mancini I, Marzaro G, dall'Acqua F, Guiotto A, Gambari R.
    Eur J Med Chem; 2011 Oct 20; 46(10):4870-7. PubMed ID: 21864947
    [Abstract] [Full Text] [Related]

  • 18. Fluorescence resonance energy transfer-based method for detection of DNA binding activities of nuclear factor kappaB.
    He HJ, Pires R, Zhu TN, Zhou A, Gaigalas AK, Zou S, Wang L.
    Biotechniques; 2007 Jul 20; 43(1):93-8. PubMed ID: 17695258
    [Abstract] [Full Text] [Related]

  • 19. Dimeric procyanidins are inhibitors of NF-kappaB-DNA binding.
    Mackenzie GG, Delfino JM, Keen CL, Fraga CG, Oteiza PI.
    Biochem Pharmacol; 2009 Nov 01; 78(9):1252-62. PubMed ID: 19591805
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
    Shin HM, Byung Hak Kim, Eun Yong Chung, Jung SH, Yeong Shik Kim, Kyung Rak Min, Kim Y.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):1-8. PubMed ID: 16183054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.